GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human rxralpha ligand binding domain in complex with 2,4-di-tert-butylphenol and a coactivator fragment

Analyse Crystal structure of human rxralpha ligand binding domain in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7NKE
Type
protein
Length
446 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P19793, Q15596
Ligands
UGW

Structure

x-ray diffraction · 2 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A, C—protein213—P19793
B, D—protein10—Q15596

Ligands and binding sites

  • UGW · 2,4-di~{tert}-butylphenol · ligand · 2 copies · chains A, C
  • FMT · Formic acid · additive · chains C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 7NKE · Crystal structure of human RXRalpha ligand binding domain in complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.